Alison Evans
Impact in
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research
Papers in
-
- Dementia and Cognitive Impairment Research 5
- Co-authors
- Lauren Rayner (3 shared papers)Matthew Hotopf (3 shared papers)Irene J Higginson (3 shared papers)Koravangattu Valsraj (3 shared papers)Annabel Price (2 shared papers)José Luís Molinuevo (1 shared paper)Clive Ballard (1 shared paper)Ritesh P. Daya (1 shared paper)
- Journals
- BMJ Open (3 papers)Nutrients (2 papers)Frontiers in Pharmacology (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Alison Evans
32 papers receiving 701 citations
Peers
Comparison fields: 5 of 99
- Biological Psychiatry 24
- Psychiatry and Mental health 110
- Pharmacology 65
- Physiology 97
- Rehabilitation 21
Countries citing papers authored by Alison Evans
This map shows the geographic impact of Alison Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Evans more than expected).
Fields of papers citing papers by Alison Evans
This network shows the impact of papers produced by Alison Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Evans. The network helps show where Alison Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 161 | |
| 2 | 2010 | 140 | |
| 3 | 2010 | 110 | |
| 4 | 2018 | 68 | |
| 5 | 2011 | 60 | |
| 6 | 2020 | 45 | |
| 7 | 2018 | 21 | |
| 8 | 2009 | 17 | |
| 9 | 2019 | 16 | |
| 10 | 2018 | 13 | |
| 11 | 2011 | 12 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 7 | |
| 14 | 2008 | 4 | |
| 15 | 1988 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2023 | 3 | |
| 18 | Nutrition screening in patients with COPD. | 2012 | 3 |
| 19 | 2008 | 3 | |
| 20 | 2021 | 2 |
About Alison Evans
Alison Evans is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health, Cardiology and Cardiovascular Medicine, Infectious Diseases and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 721 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Body Composition Measurement Techniques (2 papers), Nutrition and Health in Aging (2 papers), Pregnancy and Medication Impact (2 papers), Reproductive Health and Contraception (2 papers), Maternal and fetal healthcare (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Biological Psychiatry (24 citations), Psychiatry and Mental health (110 citations), Pharmacology (65 citations), Physiology (97 citations) and Rehabilitation (21 citations). Alison Evans has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Lauren Rayner, Matthew Hotopf, Irene J Higginson, Koravangattu Valsraj, Annabel Price, José Luís Molinuevo, Clive Ballard, Ritesh P. Daya, Ryan E. Wiley and Matthew Norton. Their work appears in journals such as BMJ Open, Nutrients, Frontiers in Pharmacology, Pharmacoepidemiology and Drug Safety and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.